Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells

Biochemical and Biophysical Research Communications

Volumn 313, Issue 4, 2004, Pages 878-887

  Gilbert, L ^a   Toivola, J ^a   Lehtomaki E ^a   Donaldson, L ^a   Kapyla P ^a   Vuento, M ^a   Oker Blom, C ^a  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

Baculovirus; Canine parvovirus; Capsid proteins; Enhanced green fluorescent protein; Fluorescent correlation spectroscopy; Fluorescent VLP; Fusion proteins

Indexed keywords

VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CHIMERA; CONFOCAL MICROSCOPY; DOG; ELECTRON MICROSCOPY; FLUORESCENCE CORRELATION SPECTROSCOPY; FUSION GENE; GENE CONSTRUCT; INSECT CELL; INTRACELLULAR SPACE; MAMMAL CELL; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN PURIFICATION; VIRUS CAPSID; VIRUS PARTICLE;

CANINE PARVOVIRUS; INSECTA; INSERTION SEQUENCES; MAMMALIA; PARVOVIRUS; SSDNA VIRUSES; UNIDENTIFIED BACULOVIRUS;

EID: 0346728738     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.176     Document Type: Article

References (52)

1. Parrish C.R. Pathogenesis of feline panleukopenia virus and canine parvovirus. Baillieres Clin. Haematol. 8:1995;57-71.
2. Cotmore S.F., Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33:1987;91-174.
3. Paradiso P.R., Rhode 3rd S.L., Singer II Canine parvovirus: a biochemical and ultrastructural characterization. J. Gen. Virol. 62(Pt 1):1982;113-125.
4. Tsao J., Chapman M.S., Agbandje M., Keller W., Smith K., Wu H., Luo M., Smith T.J., Rossmann M.G., Compans R.W.et al. The three-dimensional structure of canine parvovirus and its functional implications. Science. 251:1991;1456-1464.
5. Saliki J.T., Mizak B., Flore H.P., Gettig R.R., Burand J.P., Carmichael L.E., Wood H.A., Parrish C.R. Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J. Gen. Virol. 73(Pt 2):1992;369-374.
6. Lopez de Turiso J.A., Cortes E., Martinez C., Ruiz de Ybanez R., Simarro I., Vela C., Casal I. Recombinant vaccine for canine parvovirus in dogs. J. Virol. 66:1992;2748-2753.
7. Choi J.Y., Woo S.D., Lee H.K., Hong H.K., Je Y.H., Park J.H., Song J.Y., An S.H., Kang S.K. High-level expression of canine parvovirus VP2 using Bombyx mori nucleopolyhedrovirus vector. Arch. Virol. 145:2000;171-177.
8. Xie Q., Chapman M.S. Canine parvovirus capsid structure, analyzed at 2.9. Å resolution J. Mol. Biol. 264:1996;497-520.
9. Wu H., Rossmann M.G. The canine parvovirus empty capsid structure. J. Mol. Biol. 233:1993;231-244.
10. Chapman M.S., Rossmann M.G. Structure, sequence, and function correlations among parvoviruses. Virology. 194:1993;491-508.
11. Agbandje M., McKenna R., Rossmann M.G., Strassheim M.L., Parrish C.R. Structure determination of feline panleukopenia virus empty particles. Proteins. 16:1993;155-171.
12. Cortes E., San Martin C., Langeveld J., Meloen R., Dalsgaard K., Vela C., Casal I. Topographical analysis of canine parvovirus virions and recombinant VP2 capsids. J. Gen. Virol. 74(Pt 9):1993;2005-2010.
13. Casal J.I., Langeveld J.P., Cortes E., Schaaper W.W., van Dijk E., Vela C., Kamstrup S., Meloen R.H. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J. Virol. 69:1995;7274-7277.
14. Langeveld J.P., Casal J.I., Cortes E., van de Wetering G., Boshuizen R.S., Schaaper W.M., Dalsgaard K., Meloen R.H. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine. 12:1994;1473-1480.
15. Sabara M., Parker M., Aha P., Cosco C., Gibbons E., Parsons S., Babiuk L.A. Assembly of double-shelled rotavirus like particles by simultaneous expression of recombinant VP6 and VP7 proteins. J. Virol. 65:1991;6994-6997.
16. Urakawa T., Ferguson M., Minor P.D., Cooper J., Sullivan M., Almond J.W., Bishop D.H. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. J. Gen. Virol. 70(Pt 6):1989;1453-1463.
17. French T.J., Roy P. Synthesis of bluetongue virus (BTV) core-like particles by a recombinant baculovirus expressing the two major structural core proteins of BTV. J. Virol. 64:1990;1530-1536.
18. Plana-Duran J., Bastons M., Rodriguez M.J., Climent I., Cortes E., Vela C., Casal I. Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease. Arch. Virol. 141:1996;1423-1436.
19. Rose R.C., Bonnez W., Reichman R.C., Garcea R.L. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J. Virol. 67:1993;1936-1944.
20. Thomsen D.R., Roof L.L., Homa F.L. Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J. Virol. 68:1994;2442-2457.
21. Hoque M., Shimizu N., Ishizu K., Yajima H., Arisaka F., Suzuki K., Watanabe H., Handa H. Chimeric virus-like particle formation of adeno-associated virus. Biochem. Biophys. Res. Commun. 266:1999;371-376.
22. Brown C.S., Van Lent J.W., Vlak J.M., Spaan W.J. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J. Virol. 65:1991;2702-2706.
23. Kajigaya S., Fujii H., Field A., Anderson S., Rosenfeld S., Anderson L.J., Shimada T., Young N.S. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc. Natl. Acad. Sci. USA. 88:1991;4646-4650.
24. Rueda P., Fominaya J., Langeveld J.P., Bruschke C., Vela C., Casal J.I. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine. 19:2000;726-734.
25. Casal J.I. Use of parvovirus-like particles for vaccination and induction of multiple immune responses. Biotechnol. Appl. Biochem. 29(Pt 2):1999;141-150.
26. Miyamura K., Kajigaya S., Momoeda M., Smith-Gill S.J., Young N.S. Parvovirus particles as platforms for protein presentation. Proc. Natl. Acad. Sci. USA. 91:1994;8507-8511.
27. Mottershead D., van der Linden I., von Bonsdorff C.H., Keinanen K., Oker-Blom C. Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem. Biophys. Res. Commun. 238:1997;717-722.
28. Ludin B., Matus A. GFP illuminates the cytoskeleton. Trends Cell Biol. 8:1998;72-77.
29. Gerdes H.H., Kaether C. Green fluorescent protein: applications in cell biology. FEBS Lett. 389:1996;44-47.
30. Charpilienne A., Nejmeddine M., Berois M., Parez N., Neumann E., Hewat E., Trugnan G., Cohen J. Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells. J. Biol. Chem. 276:2001;29361-29367.
31. Elson E.L. Fluorescence correlation spectroscopy measures molecular transport in cells. Traffic. 2:2001;789-796.
32. Yoshida N., Kinjo M., Tamura M. Microenvironment of endosomal aqueous phase investigated by the mobility of microparticles using fluorescence correlation spectroscopy. Biochem. Biophys. Res. Commun. 280:2001;312-318.
33. Chen Y., Muller J.D., Ruan Q., Gratton E. Molecular brightness characterization of EGFP in vivo by fluorescence fluctuation spectroscopy. Biophys. J. 82:2002;133-144.
34. Toivola J., Ojala K., Michel P.O., Vuento M., Oker-Blom C. Properties of baculovirus particles displaying GFP analyzed by fluorescence correlation spectroscopy. Biol. Chem. 383:2002;1941-1946.
35. Luckow V.A., Lee S.C., Barry G.F., Olins P.O. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 67:1993;4566-4579.
36. S. Summer, K. Smith, A manual of methods for baculovirus vectors and insect cell culture procedures., ed., Texas Agric. Exp. Station Bull., 1987.
37. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
38. Strassheim M.L., Gruenberg A., Veijalainen P., Sgro J.Y., Parrish C.R. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology. 198:1994;175-184.
39. Griffiths G., McDowall A., Back R., Dubochet J. On the preparation of cryosections for immunocytochemistry. J. Ultrastruct. Res. 89:1984;65-78.
40. Suikkanen S., Saajarvi K., Hirsimaki J., Valilehto O., Reunanen H., Vihinen-Ranta M., Vuento M. Role of recycling endosomes and lysosomes in dynein-dependent entry of canine parvovirus. J. Virol. 76:2002;4401-4411.
41. Brown C.S., Welling-Wester S., Feijlbrief M., Van Lent J.W., Spaan W.J. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes. Virology. 198:1994;477-488.
42. Casal J.I., Rueda P., Hurtado A. Parvovirus-like particles as vaccine vectors. Methods. 19:1999;174-186.
43. Lo-Man R., Rueda P., Sedlik C., Deriaud E., Casal I., Leclerc C. A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant. Eur. J. Immunol. 28:1998;1401-1407.
44. Rueda P., Martinez-Torrecuadrada J.L., Sarraseca J., Sedlik C., del Barrio M., Hurtado A., Leclerc C., Casal J.I. Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses. Vaccine. 18:1999;325-332.
45. Hurtado A., Rueda P., Nowicky J., Sarraseca J., Casal J.I. Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles. J. Virol. 70:1996;5422-5429.
46. Kawase M., Momoeda M., Young N.S., Kajigaya S. Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation. J. Virol. 69:1995;6567-6571.
47. Pillet S., Annan Z., Fichelson S., Morinet F. Identification of a nonconventional motif necessary for the nuclear import of the human parvovirus B19 major capsid protein (VP2). Virology. 306:2003;25-32.
48. Girod A., Ried M., Wobus C., Lahm H., Leike K., Kleinschmidt J., Deleage G., Hallek M. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat. Med. 5:1999;1438.
49. Sadeyen J.R., Tourne S., Shkreli M., Sizaret P.Y., Coursaget P. Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope. Virology. 309:2003;32-40.
50. Parker J.S., Murphy W.J., Wang D., O'Brien S.J., Parrish C.R. Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J. Virol. 75:2001;3896-3902.
51. Vihinen-Ranta M., Kalela A., Makinen P., Kakkola L., Marjomaki V., Vuento M. Intracellular route of canine parvovirus entry. J. Virol. 72:1998;802-806.
52. Basak S., Turner H. Infectious entry pathway for canine parvovirus. Virology. 186:1992;368-376.